ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
4 |
12:35 |
12:35 |
ASX - By Stock
|
265
|
41K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
4 |
12:34 |
12:34 |
ASX - By Stock
|
265
|
41K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
6 |
11:51 |
11:51 |
ASX - By Stock
|
265
|
41K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
265
|
41K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
265
|
41K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
8 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
265
|
41K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
9 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
265
|
41K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
265
|
41K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP Presents at Major International Cell Therapy Conference
|
|
truss20
|
20 |
3.8K |
9 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
20
|
3.8K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
8 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
265
|
41K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
truss20
|
243 |
84K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
243
|
84K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
truss20
|
243 |
84K |
4 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
243
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
truss20
|
243 |
84K |
3 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
243
|
84K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
truss20
|
243 |
84K |
4 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
243
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
truss20
|
243 |
84K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
243
|
84K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
9 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
265
|
41K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
truss20
|
243 |
84K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
243
|
84K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
5 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
265
|
41K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
8 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
265
|
41K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
13 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
265
|
41K
|
13
|
|
ASX - By Stock
|
KAR |
Re:
Ann: Results of the Annual General Meeting
|
|
truss20
|
69 |
18K |
5 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
69
|
18K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
13 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
265
|
41K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Further GvHD Clinical Data Published in Nature Medicine
|
|
truss20
|
9 |
2.2K |
5 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
9
|
2.2K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
truss20
|
41 |
7.2K |
7 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
41
|
7.2K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
truss20
|
41 |
7.2K |
7 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
41
|
7.2K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
truss20
|
41 |
7.2K |
12 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
41
|
7.2K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
truss20
|
41 |
7.2K |
6 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
41
|
7.2K
|
6
|
|
ASX - By Stock
|
KAR |
Re:
voting mechanics for new shareholders
|
|
truss20
|
10 |
2.2K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
10
|
2.2K
|
1
|
|
ASX - By Stock
|
KAR |
Re:
voting mechanics for new shareholders
|
|
truss20
|
10 |
2.2K |
0 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
10
|
2.2K
|
0
|
|
ASX - By Stock
|
KAR |
Re:
voting mechanics for new shareholders
|
|
truss20
|
10 |
2.2K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
10
|
2.2K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
11 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
265
|
41K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
8 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
265
|
41K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
truss20
|
265 |
41K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
265
|
41K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
truss20
|
38 |
7.3K |
5 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
38
|
7.3K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
truss20
|
28 |
7.1K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
28
|
7.1K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
3 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
61
|
11K
|
3
|
|
ASX - By Stock
|
EML |
Re:
Ann: EML Announces Sale of Sentenial Business
|
|
truss20
|
66 |
23K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
66
|
23K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
11K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
11K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
11K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
truss20
|
19 |
3.3K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
19
|
3.3K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
11K
|
2
|
|
ASX - By Stock
|
EML |
Re:
Ann: EML Announces Sale of Sentenial Business
|
|
truss20
|
66 |
23K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
66
|
23K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
truss20
|
19 |
3.3K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
3.3K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
truss20
|
2.1K |
686K |
6 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
2.1K
|
686K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
truss20
|
2.1K |
686K |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
2.1K
|
686K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
truss20
|
2.1K |
686K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
2.1K
|
686K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
61
|
11K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
truss20
|
2.1K |
686K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
2.1K
|
686K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
truss20
|
61 |
11K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
61
|
11K
|
4
|
|